Randomised prospective trial to assess the clinical utility of multianalyte assay panel with complement activation products for the diagnosis of SLE. (Record no. 4675)

MARC details
000 -LEADER
fixed length control field 03285nam a22003737a 4500
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 191014s20192019 xxu||||| |||| 00| 0 eng d
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER
International Standard Serial Number 2053-8790
024 ## - OTHER STANDARD IDENTIFIER
Standard number or code 10.1136/lupus-2019-000349 [doi]
024 ## - OTHER STANDARD IDENTIFIER
Standard number or code lupus-2019-000349 [pii]
024 ## - OTHER STANDARD IDENTIFIER
Standard number or code PMC6762037 [pmc]
040 ## - CATALOGING SOURCE
Original cataloging agency Ovid MEDLINE(R)
099 ## - LOCAL FREE-TEXT CALL NUMBER (OCLC)
PMID 31592328
245 ## - TITLE STATEMENT
Title Randomised prospective trial to assess the clinical utility of multianalyte assay panel with complement activation products for the diagnosis of SLE.
251 ## - Source
Source Lupus Science & Medicine. 6(1):e000349, 2019.
252 ## - Abbreviated Source
Abbreviated source Lupus sci. med.. 6(1):e000349, 2019.
253 ## - Journal Name
Journal name Lupus science & medicine
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Year 2019
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Manufacturer FY2020
265 ## - SOURCE FOR ACQUISITION/SUBSCRIPTION ADDRESS [OBSOLETE]
Publication status epublish
266 ## - Date added to catalog
Date added to catalog 2019-10-14
520 ## - SUMMARY, ETC.
Abstract Conclusion: Our data suggest that MAP/CB-CAPs testing has clinical utility in facilitating SLE diagnosis and treatment decisions. Copyright (c) Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.
520 ## - SUMMARY, ETC.
Abstract Methods: Patients (n=145) with a history of positive antinuclear antibody status were evaluated clinically by rheumatologists and randomised to SDLT arm (tests ordered at the discretion of the rheumatologists) or to MAP/CB-CAPs testing arm. The primary endpoint was based on the change in the physician likelihood of SLE on a five-point Likert scale collected before and after testing. Changes in pharmacological treatment based on laboratory results were assessed in both arms. Statistical analysis consisted of Wilcoxon and Fisher's exact tests.
520 ## - SUMMARY, ETC.
Abstract Objective: We compared the physician-assessed diagnostic likelihood of SLE resulting from standard diagnosis laboratory testing (SDLT) to that resulting from multianalyte assay panel (MAP) with cell-bound complement activation products (MAP/CB-CAPs), which reports a two-tiered index test result having 80% sensitivity and 86% specificity for SLE.
520 ## - SUMMARY, ETC.
Abstract Results: At enrolment, patients randomised to SDLT (n=73, age=48+/-2 years, 94% females) and MAP/CB-CAPs testing arms (n=72, 50+/-2 years, 93% females) presented with similar pretest likelihood of SLE (1.42+/-0.06 vs 1.46+/-0.06 points, respectively; p=0.68). Post-test likelihood of SLE resulting from randomisation in the MAP/CB-CAPs testing arm was significantly lower than that resulting from randomisation to SDLT arm on review of test results (-0.44+/-0.10 points vs -0.19+/-0.07 points) and at the 12-week follow-up visit (-0.61+/-0.10 points vs -0.31+/-0.10 points) (p<0.05). Among patients randomised to the MAP/CB-CAPs testing arm, two-tiered positive test results associated significantly with initiation of prednisone (p=0.034).
546 ## - LANGUAGE NOTE
Language note English
650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element IN PROCESS -- NOT YET INDEXED
651 ## - SUBJECT ADDED ENTRY--GEOGRAPHIC NAME
Institution MedStar Washington Hospital Center
656 ## - INDEX TERM--OCCUPATION
Department Medicine/Rheumatology
657 ## - INDEX TERM--FUNCTION
Medline publication type Journal Article
700 ## - ADDED ENTRY--PERSONAL NAME
Local Authors Loupasakis, Konstantinos
790 ## - Authors
All authors Alexander RV, Alper J, Dervieux T, Fondal M, Hojjati M, Ibarra C, Kataria R, Khosroshahi A, Loupasakis K, Massarotti E, Narain S, O'Malley T, Powell T, Sherrer Y, Wallace DJ, Weinstein A
856 ## - ELECTRONIC LOCATION AND ACCESS
DOI <a href="https://dx.doi.org/10.1136/lupus-2019-000349">https://dx.doi.org/10.1136/lupus-2019-000349</a>
Public note https://dx.doi.org/10.1136/lupus-2019-000349
942 ## - ADDED ENTRY ELEMENTS (KOHA)
Koha item type Journal Article
Item type description Article
Holdings
Withdrawn status Lost status Damaged status Not for loan Collection Home library Current library Date acquired Total Checkouts Full call number Barcode Date last seen Price effective from Koha item type
          MedStar Authors Catalog MedStar Authors Catalog 10/14/2019   31592328 31592328 10/14/2019 10/14/2019 Journal Article

Powered by Koha